On October 23, PIPC submitted comments on the Institute for Clinical and Economic Review's (ICER) assessment of Pulmonary Arterial Hypertension (PAH) treatments. |
Over 75 Leading Patient Groups Join PIPC Comment Letter on ICER 2024 Value Assessment Framework6/30/2023
|
Topics
All
Archives
May 2024
|